Interaction and inhibitory cross-talk between endothelin and ErbB receptors in the adult heart

Molecular Pharmacology

Volumn 71, Issue 6, 2007, Pages 1494-1502

  Ka, Young Chung ^a   Walker, Jeffery W ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR AFFECTING AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 4; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; MALEIMIDE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; NEUROREGULIN 1BETA; PHORBOL ESTER; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C BETA1; PROTEIN; PROTEIN KINASE B; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; RAF PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARDIOMYOPATHY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CROSS REACTION; DESORPTION; DOWNSTREAM PROCESSING; DRUG TARGETING; HEART; HEART DEVELOPMENT; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE; IMMUNOPRECIPITATION; INHIBITION KINETICS; INOTROPISM; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; RAT; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSVERSE TUBULAR SYSTEM; VALIDATION PROCESS; WESTERN BLOTTING;

ANIMALS; HEART; MALE; MYOCARDIUM; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR CROSS-TALK; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTORS, ENDOTHELIN; SIGNAL TRANSDUCTION;

EID: 34347344027     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.027599     Document Type: Article

References (32)

1. Adams JW, Sakata Y, Davis MG, Sah VP, Wang Y, Liggett SB, Chien KR, Brown JH, and Dorn GW 2nd (1998) Enhanced Gαq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci USA 97:10140-10145.
2. Anderson HD, Wang F, and Gardner DG (2004) Role of the epidermal growth factor receptor in signaling strain-dependent activation of the brain natriuretic peptide gene. J Biol Chem 279:9287-9297.
3. Asakura M, Kitakaze M, Takashima S, Liao Y, Ishikura F, Yoshinaka T, Ohmoto H, Node K, Yoshino K, Ishiguro H, et al. (2002) Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med 8:35-40.
4. Balijepalli RC, Lokuta AJ, Maertz NA, Buck JM, Haworth RA, Valdivia HH, and Kamp TJ (2003) Depletion of T-tubules and specific subcellular changes in sarcolemmal proteins in tachycardia-induced heart failure. Cardiovasc Res 59:67-77.
5. Brette F and Orchard C (2003) T-tubule function in mammalian cardiac myocytes. Circ Res 92:1182-1192.
6. Chien KR (2006) Herceptin and the heart - a molecular modifier of cardiac failure. N Engl J Med 354:789-790.
7. Daub H, Weiss FU, Wallasch C, and Ullrich A (1996) Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature (Lond) 379:557-560.
8. Grazette LP, Boecker W, Matsui T, Semigran M, Force TL, Hajjar RJ, and Rosenzweig A (2004) Inhibition of ErbB2 causes mitochondrial dysfunction in cardiomyocytes: implications for herceptin-induced cardiomyopathy. J Am Coll Cardiol 44:2231-2238.
9. Grewal JS, Luttrell LM, and Raymond JR (2001) G protein-coupled receptors desensitize and down-regulate epidermal growth factor receptors in renal mesangial cells. J Biol Chem 276:27335-27344.
10. Goraca A (2002) New views on the role of endothelin. Endocr Regul 36:161-167.
11. Huang XP, Pi Y, Lokuta AJ, Greaser ML, and Walker JW (1997) Arachidonic acid stimulates protein kinase C-epsilon redistribution in heart cells. J Cell Sci 110 (Pt 14):1625-1634.
12. Huang XP, Sreekumar R, Patel JR, and Walker JW (1996) Response of cardiac myocytes to a ramp increase of diacylglycerol generated by photolysis of a novel caged diacylglycerol. Biophys J 70:2448-2457.
13. Iwamoto R, Yamazaki S, Asakura M, Takashima S, Hasuwa H, Miyado K, Adachi S, Kitakaze M, Hashimoto K, Raab G, et al. (2003) Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc Natl Acad Sci USA 100:3221-3226.
14. Jiang ZY, Zhou QL, Chatterjee A, Feener EP, Myers MG Jr, White MF, and King GL (1999) Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Diabetes 48:1120-1130.
15. Kedzierski RM and Yanagisawa M (2001) Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol 41:851-876.
16. Lemmens K, Fransen P, Sys SU, Brutsaert DL, and De Keulenaer GW (2004) Neuregulin-1 induces a negative inotropic effect in cardiac muscle: role of nitric oxide synthase. Circulation 109:324-326.
17. TA receptor antagonist. Circulation 101:142-147.
18. Negro A, Brar BK, and Lee KF (2004) Essential roles of Her2/ErbB2 in cardiac development and function. Recent Prog Horm Res 59:1-12.
19. Pieske B, Beyermann B, Breu V, Loffler BM, Schlotthauer K, Maier LS, Schmidt-Schweda S, Just H, and Hasenfuss G (1999) Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium. Circulation 99:1802-1809.
20. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, and Ullrich A (1999) EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of ProHB-EGF. Nature (Lond) 402:884-888.
21. Robu VG, Pfeiffer ES, Robia SL, Balijepalli RC, Pi Y, Kamp TJ, and Walker JW (2003) Localization of functional endothelin receptor signaling complexes in cardiac transverse tubules. J Biol Chem 278:48154-481561.
22. Rohrbach S, Niemann B, Silber RE, and Holtz J (2005) Neuregulin receptors ErbB2 and ErbB4 in failing human myocardium-depressed expression and attenuated activation. Basic Res Cardiol 100:240-249.
23. q agonist Pasteurella multocida toxin to promote cardiomyocyte hypertrophy and enhance apoptosis susceptibility. Circ Res 90:850-857.
24. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, and Sugishita Y (1996) Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature (Lond) 384:353-355.
25. Shah BH and Catt KJ (2004) Matrix metalloproteinase-dependent EGF receptor activation in hypertension and left ventricular hypertrophy. Trends Endocrinol Metab 15:241-243.
26. Smith NJ, Chan HW, Osborne JE, Thomas WG, and Hannan RD (2004) Hijacking epidermal growth factor receptors by angiotensin II: new possibilities for understanding and treating cardiac hypertrophy. Cell Mol Life Sci 61:2695-2703.
27. Sugden PH (2003) An overview of endothelin signaling in the cardiac myocyte. J Mol Cell Cardiol 35:871-886.
28. Thomas PB, Liu EC, Webb ML, Mukherjee R, Hebbar L, and Spinale FG (1996) Exogenous effects and endogenous production of endothelin in cardiac myocytes: potential significance in heart failure. Am J Physiol 271:H2629-H2637.
29. Velloso LA, Folli F, Perego L, and Saad MJA (2006) The multi-faceted cross-talk between the insulin and angiotensin II signaling systems. Diabetes Metab Res Rev 22:98-107.
30. Waters C, Pyne S, and Pyne NJ (2004) The role of G-protein coupled receptors and associated proteins in receptor tyrosine kinase signal transduction. Semin Cell Dev Biol 15:309-323.
31. Yarden Y and Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127-137.
32. Zhao YY, Sawyer DR, Baliga RR, Opel DJ, Han X, Marchionni MA, and Kelly RA (1998) Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes. J Biol Chem 273:10261-10269.